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Objective/purpose
In asthmatic individuals, airway narrowing represents
the early phase of the asthmatic response to allergen
inhalation challenge, occurring within thirty minutes [1].
In 50-60% of allergic asthmatic adults, the early
response is followed by the late phase asthmatic
response, usually starting between 3-4 hours after aller-
gen inhalation challenge [2], and characterized mainly
by cellular inflammation of the airway [3]. The pathways
leading to the late response are not completely under-
stood. Understanding these pathways is important for
evaluating allergic diseases such as asthma. In contrast
to the more transient isolated early response, develop-
ment of the late response is associated with the hall-
mark inflammatory features of chronic allergic disease.
Methods
Nine adult subjects participating in ethically approved
allergen challenge studies were recruited following
informed consent. Inclusion criteria included non-smo-
kers with stable, mild to moderate atopic asthma, free of
other lung diseases. Subjects developing either an iso-
lated early asthmatic response (≥20% drop in FEV1
within 2 hours) or the dual asthmatic response (early
response + ≥15% drop in FEV1 between 3-7 hours)
were studied. Peripheral blood was drawn just prior to
inhalation challenge and 2-3 hours post-challenge. Gene
expression analysis was performed using Affymetrix
GeneChip® microarrays.
Findings
1783 genes were differentially expressed between pre-
and post-inhalation challenge (p ≤ 0.01). 364 genes
remained significant at an FDR of 10%. Within this set,
the DNAJC1 gene (p = 7.2e-5) has been previously iden-
tified in a GWAS (genome-wide association study) as
associated with asthma. Gene ontology showed per-
turbed activity in immune system process, mast cell
secretory granules and immunoglobulin biosynthesis.
Deliverables
The peripheral blood transcriptome was perturbed
between pre-allergen inhalation challenge and 2-3 hours
post-challenge, with a focus on immunological func-
tions. DNAJC1 was identified to be a gene for possible
further investigation. Additional recruitment of subjects
is underway to identify more specific biological path-
ways that may be relevant to the onset of the late asth-
matic response.
Relevance
This research will act as an initial step in identifying
genes and pathways that may be involved in the more
clinically severe late asthmatic response that follows the
early response in more than half of the asthmatic popu-
lation. The discovery of these biological pathways will
allow for a better understanding of why some indivi-
duals develop a dual response instead of an isolated
early response. It will also indicate potential therapeutic
targets that can be utilized to minimize the late asth-
matic response, leading to better treatments for people
with asthma and other allergies.
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